1392809-41-4

Upstream product

• 1257296-40-4 tert-butyl 3-bromo-1H-indazole-1-carboxylate 
• 851199-66-1 1-(4-methoxybenzyl)-5-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-tetrazole 
• 171364-82-2 4-cyanophenylboronic acid pinacol ester 

Downstream Products

• 1392809-31-2 3-(4-(1H-tetrazol-5-yl)phenyl)-1-(3-chlorophenylsulfonyl)-1H-indazole 
• 1392809-42-5 1-(3-chlorophenylsulfonyl)-3-(4-(1-(4-methoxybenzyl)-1H-tetrazol-5-yl)phenyl)-1H-indazole 
• 1392809-43-6 (2,6-dichlorophenyl)(3-(4-(1-(4-methoxybenzyl)-1H-tetrazol-5-yl)phenyl)-1H-indazol-1-yl)methanone 

Relevant academic research and scientific papers

RORGAMMAT INHIBITORS

The present invention relates to compounds according to Formula (I) or a pharmaceutically acceptable salt or solvate thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or condition.

RorgammaT inhibitors

The present invention relates to compounds according to general Formula I or a pharmaceutically acceptable salt thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.